


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
MDT
Medtronic
$100.80
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market
Risk Analysis

Trading above its fair value
Chart
$95.83 (+5.19%)
$92.04 (+9.52%)
$86.02 (+17.18%)
$86.54 (+16.48%)
MDT has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

MDT overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Outperform the market

Trading above its fair value
![]()
MDT Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
MDT Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is MDT current stock price?
What are MDT stock strengths?
What is MDT Risk Level?
What is MDT market cap and volume?
What is MDT current Stock IQ?
Should I buy MDT stock right now?
Is MDT a Strong Buy right now?
What does a 'Strong Buy' rating mean for MDT?
What does a 'Strong Sell' rating mean for MDT?
What factors influence MDT's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
MDT
Medtronic
Current Price
$100.80
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market
Risk Analysis

Trading above its fair value

Chart
$95.83 (+5.19%)
$92.04 (+9.52%)
$86.02 (+17.18%)
$86.54 (+16.48%)
MDT Analysts Opinion
MDT Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Outperform the market

Trading above its fair value
![]()
MDT Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
MDT Street Sentiment is extremely bullish and have positive views on the near-term outlook
MDT has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels.
MDT Latest Analysis
Medtronic targets 5.5% FY26 revenue growth as PFA franchise surges 71%.
Today
Medtronics Q2 Earnings & Revenues Beat Estimates Stock Climbs. MDT posts Q2 earnings and revenue beat powered by strong Cardiovascular growth and a raised 2026 outlook that lifts its shares.
Today
Medtronic beats top-line and bottom-line estimates. raises FY26 outlook.
Today
Medtronic (MDT) Q2 Earnings and Revenues Top Estimates. Medtronic (MDT) delivered earnings and revenue surprises of 3.82% and 1.11% respectively for the quarter ended October 2025. Do the numbers hold clues to what lies ahead for the stock?
Today
Medtronic Beelines For A Breakout After Beat-And-Raise Quarter.
Today
Medtronic Plc Q2 Profit Increases Beats Estimates . (RTTNews) - Medtronic plc (2M6.DE) revealed a profit for its second quarter that Increased from the same period last year and beat the Street estimates.
Today
Medtronic Boosts FY26 Outlook - Update . (RTTNews) - While reporting financial results for the first quarter on Tuesday medical devices maker Medtronic plc (MDT) raised its adjusted earnings and organic revenue growth guidance for the full-year 2026 given the outperformance in the first half of the year and confidence
Today
Medtronic Stock Rises After Earnings. What Caught Investors Attention..
Today
2 Giant Healthcare Stocks to Buy Hand Over Fist in November. Key PointsMedical device maker Medtronic boasts an attractive yield and a long history of dividend growth.
Mon Nov 17, 2025
A Look at Medtronics Upcoming Earnings Report. Medtronic (NYSE:MDT) is preparing to release its quarterly earnings on Tuesday 2025-11-18. Here'.s a brief overview of what investors should keep in mind before the announcement.Analysts expect Medtronic to report an Investors in Medtronic are eagerly awaiting the company'.s announcement hoping for news of surpassing estimates and positive guidance for the next quarter.It'.s worth noting for new investors that stock prices can be heavily
Mon Nov 17, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.